BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4724998)

  • 1. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.
    Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
    Am J Epidemiol; 1973 Aug; 98(2):77-87. PubMed ID: 4724998
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. 3. Houston, Texas.
    Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
    Am J Epidemiol; 1972 Dec; 96(6):427-42. PubMed ID: 4345340
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to herpesvirus type 2 in breast cancer and cervical cancer patients.
    Adam E; Sanders EK; Melnick JL; Levy AH; Rawls WE
    Cancer; 1974 Jan; 33(1):147-52. PubMed ID: 4810088
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
    Rawls WE; Adam E; Melnick JL
    Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
    [No Abstract]   [Full Text] [Related]  

  • 7. The causative role of herpesvirus type 2 in cervical cancer.
    Melnick JL; Adam E; Rawls WE
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1375-85. PubMed ID: 4607697
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
    Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
    Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
    [No Abstract]   [Full Text] [Related]  

  • 9. The association of herpesvirus type 2 and carcinoma of the uterine cervix.
    Rawls WE; Tompkins WA; Melnick JL
    Am J Epidemiol; 1969 May; 89(5):547-54. PubMed ID: 5818824
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
    Najem SN; Barton IG; Al-Omar LS; Potter CW
    Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
    Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
    Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of associated factors, including genital herpes, in Black women with cervical carcinoma in Johannesburg.
    Freedman RS; Joosting AC; Ryan JT; Nkoni S
    S Afr Med J; 1974 Aug; 48(41):1747-52. PubMed ID: 4369733
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiologic characteristics in patients with epithelial dysplasi, carcinoma in situ, and invasive carcinoma of the uterine cervix. The population screening for cervical carcinoma in Maribo amt (county) 1967-1969.
    Berget A
    Dan Med Bull; 1975 Sep; 22(6):252-9. PubMed ID: 1175395
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
    Pacsa AS; Kummerländer L; Pejtsik B; Pali K
    J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of herpesvirus type 2 infection and cervical cancer.
    Adam E; Rawls WE; Melnick JL
    Prev Med; 1974 Mar; 3(1):122-41. PubMed ID: 4360935
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to type 1 and type 2 herpes virus in women with abnormal cervical cytology.
    Skinner GR; Thouless ME; Jordan JA
    J Obstet Gynaecol Br Commonw; 1971 Nov; 78(11):1031-8. PubMed ID: 5124558
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of association of cytomegalovirus antibody level with carcinoma of the uterine cervix.
    Hart H; Springbett A; Norval M
    Gynecol Obstet Invest; 1982; 14(4):300-8. PubMed ID: 6293940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix.
    Thomas DB
    Am J Epidemiol; 1973 Jul; 98(1):10-28. PubMed ID: 4544435
    [No Abstract]   [Full Text] [Related]  

  • 20. Cervical cancer in Yugoslavia. I. Antibodies to genital herpesvirus in cases and controls.
    Kessler II; Kulcar Z; Rawls WE; Smerdel S; Strnad M; Lilienfeld AM
    J Natl Cancer Inst; 1974 Feb; 52(2):369-76. PubMed ID: 4816000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.